Ensitrelvir reduced transmission of SARS-CoV-2 by 67% when given to uninfected household contacts of a person with COVID-19 ...

Between April 2020 and December 2022, over 535,000 people in Germany downloaded and activated the Corona Data Donation App ...

Has there been any progress in figuring out how to treat long COVID? I have been dealing with the symptoms for two years, and ...

Full COVID-19 vaccination may reduce post-COVID-19 condition risk by 27%, though more research is needed, especially for ...

People who later experienced persistent shortness of breath or fatigue after a SARS-CoV-2 infection were already taking ...

One virus that can infect the central nervous system is the SARS-CoV-2 virus, which brought about the coronavirus pandemic in 2019. Researchers became interested in the virus’s ability to infect brain ...

Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk ...

Has there been any progress in figuring out how to treat long covid? I have been dealing with the symptoms for two years, and my doctor seems to ...